Starpharma Holdings Share Price and Company Fundamentals
Last traded: Today at 2:10 AM
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It also involved in the development of a dendrimer-enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; DEP technology for antibody-drug conjugates; SPL7013 for vaginal gel, a treatment of bacterial vaginosis and prevention of recurrent BV, and an antiviral condom; and DEP HER2 radiodiagnostic. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.
Key Metrics
PE ratio
-
PB ratio
9.33
Dividend yield
-
Beta
0.49
Market cap
$176.36M
Enterprise value
$162.65M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Full time employees | 40 |
| Website | https://starpharma.com |
| Mailing address | 4-6 Southampton Crescent Abbotsford VIC 3067 Australia |
| Phone / Fax | 61 3 8532 2700 / 61 3 9510 5955 |
Dividends
More: Starpharma Holdings Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Starpharma Holdings paid $- dividend and the ex-dividend date was 25 Mar 1988.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SPL dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Starpharma Holdings.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Cheryl Maley B.Sc., M.B.A. | CEO, MD & Director | 57 | |
| Mr. Justin Cahill | CFO & Company Secretary | ||
| Ms. Sindy Smith | Communications & Investor Relations Manager | ||
| Ms. Miranda Sowden | Director of People & Culture |
Profitability and management effectiveness
Profit margin
-170.77%
Operating margin
-134.33%
Return on assets
-20.06%
Return on equity
-42.41%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Starpharma Holdings is 176.36M and its enterprise value is 162.65M. The enterprise value to revenue ratio of SPL is 27.80. The enterprise value to EBITDA ratio of SPL is -16.73.
The SPL's stocks Beta value is 0.49 making it 51% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Starpharma Holdings (SPL)
Starpharma Holdings (ASX:SPL) Frequently Asked Questions
1. What is Starpharma Holdings's Stock Symbol?
Starpharma Holdings trades on ASX under the ticker symbol "SPL".
2. What is Starpharma Holdings's stock price today?
One share of SPL stock can currently be purchased for approximately $0.42.
3. How can I contact Starpharma Holdings?
Starpharma Holdings's mailing address is 4-6 Southampton Crescent Abbotsford VIC 3067 Australia. The company can be reached via phone at 61 3 8532 2700.
4. What is Starpharma Holdings's official website?
The official website of Starpharma Holdings is https://starpharma.com.